The epigenetic regulator ALKBH5 facilitates the early adaptation of hepatocellular carcinoma cells to sorafenib treatment.
- DOI
- 10.1080/1120009x.2026.2722741
- Published
- 2026 Sep 3
- Container
- Journal of chemotherapy (Florence, Italy)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/1120009x.2026.2722741,
title = {The epigenetic regulator ALKBH5 facilitates the early adaptation of hepatocellular carcinoma cells to sorafenib treatment.},
author = {Li M and Wang J and Fang S and Dai L and Sun X and Sun F and Huang W},
year = {2026},
journal = {Journal of chemotherapy (Florence, Italy)},
doi = {10.1080/1120009x.2026.2722741},
url = {https://doi.org/10.1080/1120009x.2026.2722741}
}RIS
TY - JOUR TI - The epigenetic regulator ALKBH5 facilitates the early adaptation of hepatocellular carcinoma cells to sorafenib treatment. AU - Li M AU - Wang J AU - Fang S AU - Dai L AU - Sun X AU - Sun F AU - Huang W PY - 2026 JO - Journal of chemotherapy (Florence, Italy) DO - 10.1080/1120009x.2026.2722741 UR - https://doi.org/10.1080/1120009x.2026.2722741 ER -
APA
M, L., J, W., S, F., L, D., X, S., F, S., & W, H. (2026). The epigenetic regulator ALKBH5 facilitates the early adaptation of hepatocellular carcinoma cells to sorafenib treatment.. Journal of chemotherapy (Florence, Italy). https://doi.org/10.1080/1120009x.2026.2722741
Source records
- pubmed · retrieved 2026-09-26T02:50:57.887Z